You are here

Home » CERID Bibliography

CERID Bibliography

Export 884 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Animals  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Birkebak TA, Palmer GH, Davis WC, McElwain TF. Quantitative characterization of the CD5 bearing lymphocyte population in the peripheral blood of normal sheep. Vet Immunol Immunopathol. 1994 ;41(1-2):181-6.
Birkebak TA, Palmer GH, Davis WC, Knowles DP, McElwain TF. Association of GP51 expression and persistent CD5+ B-lymphocyte expansion with lymphomagenesis in bovine leukemia virus infected sheep. Leukemia. 1994 ;8(11):1890-9.
Blaug S, Hybiske K, Cohn J, Firestone GL, Machen TE, Miller SS. ENaC- and CFTR-dependent ion and fluid transport in mammary epithelia. Am J Physiol Cell Physiol. 2001 ;281(2):C633-48.
Bochud P-Y, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003 ;170(7):3451-4.
Boggild AK, Page AV, Keystone JS, Morris AM, W Liles C. Delay in diagnosis: malaria in a returning traveller. CMAJ. 2009 ;180(11):1129-31.
Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, W Liles C, Looareesuwan S, Kain KC. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2009 ;49(6):841-9.
Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT. The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One. 2009 ;4(4):e5063.
Boor KJ, Brown DP, Murphy SC, Kozlowski SM, Bandler DK. Microbiological and chemical quality of raw milk in New York State. J Dairy Sci. 1998 ;81(6):1743-8.
Bosch J, Robien MA, Mehlin C, Boni E, Riechers A, Buckner FS, Van Voorhis WC, Myler PJ, Worthey EA, Detitta G, et al. Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase. J Med Chem. 2006 ;49(20):5939-46.
Brannon MK, J Davis M, Mathias JR, Hall CJ, Emerson JC, Crosier PS, Huttenlocher A, Ramakrishnan L, Moskowitz SM. Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos. Cell Microbiol. 2009 ;11(5):755-68.
Brayton KA, Knowles DP, McGuire TC, Palmer GH. Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. Proc Natl Acad Sci U S A. 2001 ;98(7):4130-5.
Brayton KA, Palmer GH, Brown WC. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale. Expert Rev Vaccines. 2006 ;5(1):95-101.
Brayton KA, Meeus PFM, Barbet AF, Palmer GH. Simultaneous variation of the immunodominant outer membrane proteins, MSP2 and MSP3, during anaplasma marginale persistence in vivo. Infect Immun. 2003 ;71(11):6627-32.
Bressi JC, Choe J, Hough MT, Buckner FS, Van Voorhis WC, Verlinde CL, Hol WG, Gelb MH. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine. J Med Chem. 2000 ;43(22):4135-50.
Bressi JC, Verlinde CL, Aronov AM, Shaw ML, Shin SS, Nguyen LN, Suresh S, Buckner FS, Van Voorhis WC, Kuntz ID, et al. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem. 2001 ;44(13):2080-93.
Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M, Diamond MS. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. PLoS Pathog. 2011 ;7(9):e1002230.
Brown WC, McElwain TF, Hötzel I, Ruef BJ, Rice-Ficht AC, Stich RW, Suarez CE, Estes DM, Palmer GH. Immunodominant T-cell antigens and epitopes of Babesia bovis and Babesia bigemina. Ann Trop Med Parasitol. 1998 ;92(4):473-82.
Brown WC, McElwain TF, Palmer GH, Chantler SE, Estes DM. Bovine CD4(+) T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect Immun. 1999 ;67(1):155-64.
Brown WC, McGuire TC, Mwangi W, Kegerreis KA, Macmillan H, Lewin HA, Palmer GH. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a. Infect Immun. 2002 ;70(10):5521-32.
Brown WC, McElwain TF, Hötzel I, Suarez CE, Palmer GH. Helper T-cell epitopes encoded by the Babesia bigemina rap-1 gene family in the constant and variant domains are conserved among parasite strains. Infect Immun. 1998 ;66(4):1561-9.
Brown WC, Palmer GH, Lewin HA, McGuire TC. CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect Immun. 2001 ;69(11):6853-62.
Brown WC, Palmer GH, McElwain TF, Hines SA, Dobbelaere DA. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle. Exp Parasitol. 1993 ;77(1):97-110.
Brown WC, Rodriguez SD, Hötzel I, Ruef BJ, Chitko-McKown CG, McElwain TF, Palmer GH. Characterization of helper T cell responses against rhoptry-associated protein 1 (RAP-1) of babesial parasites. Ann N Y Acad Sci. 1996 ;791:128-35.
Brown WC, Brayton KA, Styer CM, Palmer GH. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. J Immunol. 2003 ;170(7):3790-8.
Brown WC, Shkap V, Zhu D, McGuire TC, Tuo W, McElwain TF, Palmer GH. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun. 1998 ;66(11):5406-13.

Pages